A61K 2239/29
Multispecific cars
Official title: Multispecific CARs
A61K2239/29 (Multispecific cars) appears on 125 US grants and 417 published applications in this corpus.
Search patents in A61K- Granted patents
- 125
- Published applications
- 417
- Assignees
- 177
- Inventors
- 882
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 0 | 2 |
| 2016 | 2 | 3 |
| 2017 | 3 | 8 |
| 2018 | 1 | 16 |
| 2019 | 2 | 15 |
| 2020 | 10 | 29 |
| 2021 | 12 | 41 |
| 2022 | 14 | 37 |
| 2023 | 14 | 63 |
| 2024 | 10 | 75 |
| 2025 | 32 | 68 |
| 2026 | 25 | 52 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Dual CAR expressing T cells individually linked to CD28 and 4-1BB6 Oct 2026US 12,753,218 B2The Trustees of the University of Pennsylvania
- Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof6 Oct 2026US 12,753,221 B2Abelzeta Inc.
- Humanized CD19 antibody and use thereof15 Sep 2026US 12,735,482 B2Gracell Bioscience (Shanghai) Co., Ltd.
- CAR-CD123 vector and uses thereof4 Aug 2026US 12,698,333 B2Ospedale Pediatrico Bambino Gesu'
- Disruption of telocyte activity10 Sep 2026US 2026/0263514 A1
- Method and drug for treating cancer by joint use of nkg2d chimeric antigen receptor and pd1 inhibitor27 Aug 2026US 2026/0248853 A1Daren Biotech Limited
- Antibody against c-met and use thereof20 Aug 2026US 2026/0242488 A1
- Modified gamma delta t cells20 Aug 2026US 2026/0242730 A1Pointloma Biosciences, Inc.
- Chimeric receptors and methods of use thereof13 Aug 2026US 2026/0232803 A1Senti Biosciences, Inc.
Most cited
By later US patents
- Compositions, methods, and computer systems related to making and administering modified T cells107US 9,499,855 B2Elwha LLC · 2016
- Bispecific chimeric antigen receptors and encoding polynucleotides thereof92US 9,447,194 B2Seattle Children's Hospital · 2016
- Binding-triggered transcriptional switches and methods of use thereof31US 9,670,281 B2The Regents of the University of California · 2017
- Bispecific chimeric antigen receptors and methods of use thereof to treat cancer26US 10,189,903 B2Seattle Children's Hospital · 2019
- Chimeric antigen receptors based on single domain antibodies and methods of use thereof17US 10,934,363 B2Legend Biotech USA Inc. · 2021